NA
BMY icon

Nordwand Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Nordwand Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$485K Hold
8,000
– – 0.08% 120
2025
Q4 		$432K Sell
8,000
-20
-0.2% -$962 0.08% 120
2025
Q3 		$362K Hold
8,020
– – 0.06% 130
2025
Q2 		$371K Buy
+8,020
New +$394K 0.06% 123

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nordwand Advisors's BMY Position: Q1 2026 in Review

Nordwand Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 8,000 shares worth $485K. The position accounts for 0.08% of the portfolio, ranked #120.

Nordwand Advisors first reported a position in BMY in Q2 2025 and has held it in 4 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Nordwand Advisors held 8,000 shares of Bristol-Myers Squibb worth $485K as of Q1 2026.
  • Nordwand Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.08% of Nordwand Advisors's portfolio in Q1 2026, its #120 holding.
  • Nordwand Advisors first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 4 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Nordwand Advisors's 13F filing for Q1 2026, filed 7 May 2026.